Tagra Biotechnologies
Microencapsulation Technology for Cosmetic Ingredients
Company Overview
Snapshot
Founded in June 1998 by Ron Folman, Tagra Biotechnologies operates with 11–50 employees. The company specializes in microencapsulation technology for cosmetic ingredients, a field it has been innovating in for over two decades. In February 2020, Caldic UK Ltd signed an agreement with Tagra Biotechnologies, expanding its market reach.
Business overview
Tagra Biotechnologies develops and manufactures cosmetic ingredients, leveraging its proprietary microencapsulation technology and skin delivery systems. The company focuses on overcoming technical challenges in cosmetic formulation to create innovative beauty products. Its ingredients are globally compliant, free of preservatives, surfactants, and allergens, Halal certified, non-nano-sized, and not tested on animals. Tagra's microencapsulations create visual and sensory effects, such as color and texture transitions, and deliver stabilized actives with release on demand for enhanced anti-aging benefits. The company operates within the Health Tech & Life Sciences sector, specifically targeting the Pharma & Medical Biotechnology and Cosmetic Materials industries.
Strategic signal
In February 2020, Caldic UK Ltd signed a distribution agreement with Tagra Biotechnologies. This partnership signals Tagra's continued expansion into key European markets, validating its microencapsulation technology and product portfolio as attractive to established distributors seeking innovative cosmetic ingredient solutions.
Log in to access full profile ›Company Intelligence Q&A
- When was Tagra Biotechnologies founded?
- Tagra Biotechnologies was founded in June 1998.
- Who is the founder of Tagra Biotechnologies?
- Ron Folman is the founder and CEO of Tagra Biotechnologies.
- What significant agreement did Tagra Biotechnologies sign in 2020?
- In February 2020, Caldic UK Ltd signed an agreement with Tagra Biotechnologies to distribute its products.
- How has Tagra Biotechnologies advanced cosmetic microencapsulation?
- In April 2019, Tagra Biotechnologies improved cosmetic microencapsulation techniques to create new user experiences, focusing on visual and sensory effects.
- What was the nature of the partnership between Azelis and Tagra Biotechnologies?
- In August 2017, Azelis strengthened its ties with Tagra Biotechnologies through an exclusive distribution agreement in China, expanding Tagra's presence in the Asia Pacific market.